![Samuel K. Ackerman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Samuel K. Ackerman
Amministratore Delegato presso
Cyclis Pharmaceuticals, Inc.
Profilo
Samuel K.
Ackerman is the founder of Pentose Pharmaceuticals, Inc. He currently holds the position of President & Chief Executive Officer at Cyclis Pharmaceuticals, Inc. and Chairman at Vitex Systems, Inc. Previously, he served as Chairman & Chief Executive Officer at V.I.
Technologies, Inc. from 1999 to 2005, Chairman, President & Chief Executive Officer at Panacos Pharmaceuticals, Inc. from 2005 to 2006, and as a Principal at OraVax, Inc. in 1995.
He also worked as a Partner at Ampersand Management LLC.
Posizioni attive di Samuel K. Ackerman
| Società | Posizione | Inizio |
|---|---|---|
Cyclis Pharmaceuticals, Inc.
 Cyclis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops small molecule drugs for the treatment of cancer | Amministratore Delegato | - |
Vitex Systems, Inc. | Presidente | - |
Precedenti posizioni note di Samuel K. Ackerman
| Società | Posizione | Fine |
|---|---|---|
| PANACOS PHARMACEUTICALS, INC. | Amministratore Delegato | 15/06/2006 |
V.I. Technologies, Inc.
 V.I. Technologies, Inc. BiotechnologyHealth Technology Develops blood products and systems using its proprietary viral inactivation technologies | Presidente | 01/08/2005 |
OraVax, Inc.
 OraVax, Inc. BiotechnologyHealth Technology Develops oral vaccines and non injected antibody products | Corporate Officer/Principal | 31/12/1995 |
Pentose Pharmaceuticals, Inc.
 Pentose Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel antiviral products | Fondatore | - |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Investitore di Private Equity | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
12
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
OraVax, Inc.
OraVax, Inc. BiotechnologyHealth Technology Develops oral vaccines and non injected antibody products | Health Technology |
V.I. Technologies, Inc.
V.I. Technologies, Inc. BiotechnologyHealth Technology Develops blood products and systems using its proprietary viral inactivation technologies | Health Technology |
Vitex Systems, Inc. | |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Pentose Pharmaceuticals, Inc.
Pentose Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel antiviral products | Health Technology |
Cyclis Pharmaceuticals, Inc.
Cyclis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops small molecule drugs for the treatment of cancer | Health Technology |
Panacos Pharmaceuticals, Inc.
 Panacos Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small molecule drugs | Health Technology |
